Astex - PDFSEARCH.IO - Document Search Engine

Astex
Results: 79

#	Item
51	May 16, 2012 Astex Pharmaceuticals to Present at ASCO Annual Meeting DUBLIN, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and de Add to Reading List Source URL: astx.com Language: English
52	Astex Pharmaceuticals Reports 2011 Fourth Quarter and Year-End Financial Results Reports Annual Net Income of $5.5 Million Dacogen Royalty Revenue Increases 15% from Prior Year Ends Year with $128 Million in Cash & Marke Add to Reading List Source URL: astx.com Language: English Business Taxation Amortization Balance sheet Deferral Financial ratio Net income Goodwill Expense Accountancy Generally Accepted Accounting Principles Finance
53	October 31, 2012 Astex Pharmaceuticals to Present at EORTC-NCI-AACR DUBLIN, Calif., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and de Add to Reading List Source URL: astx.com Language: English
54	Astex Announces Commencement of Phase I Study for AZD5363 in Anti-Cancer Collaboration with AstraZeneca Cambridge, UK, 12th April[removed]Astex Therapeutics, the UK-based biotechnology company developing targeted therapies Add to Reading List Source URL: astx.com Language: English Institute of Cancer Research AstraZeneca Cancer research AKT Pharmaceutical industry London Astex Medicine Pharmaceutical sciences
55	June 20, 2013 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO) Correlation of Biomarkers and DNA Methylation to Clinical Responses DUBLIN, Cali Add to Reading List Source URL: astx.com Language: English Myeloid leukemia Biomarker Astex Medicine Acute leukemia Acute myeloid leukemia
56	July 22, 2013 Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models Data Presented at 8th Wor Add to Reading List Source URL: astx.com Language: English Organofluorides Alkynes Melanoma Organochlorides Vemurafenib Hsp90 Astex Targeted therapy Erlotinib Chemistry Organic chemistry Medicine
57	August 28, 2013 Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study SGI-110 Phase 2 Shows Clear Activity in Patients With Acute Myeloid Leukemia DUBLIN, Calif., Aug. 28, 2013 (GLOBE NEWSWIRE) -- Add to Reading List Source URL: astx.com Language: English Astex Leukemia Acute leukemia Myeloid leukemia Acute myeloid leukemia
58	Astex Pharmaceuticals to Announce 2012 First Quarter Financial Results on April 30, 2012 DUBLIN, Calif., April 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to Add to Reading List Source URL: astx.com Language: English
59	October 23, 2012 Astex Pharmaceuticals to Announce 2012 Third Quarter Financial Results on October 30, 2012 DUBLIN, Calif, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical co Add to Reading List Source URL: astx.com Language: English
60	April 3, 2013 Astex Pharmaceuticals Pipeline Data Presentations at AACR DUBLIN, Calif., April 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery an Add to Reading List Source URL: astx.com Language: English Astex American Association for Cancer Research Prostate cancer

UPDATE